Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Pharmacopsychiatry

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    March 2018
  1. KISHI T, Matsui Y, Matsuda Y, Katsuki A, et al
    Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2018 Mar 7. doi: 10.1055/a-0574-0088.
    PubMed     Text format     Abstract available


  2. ROSER P, Pichler EM, Habermeyer B, Kawohl W, et al
    Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients.
    Pharmacopsychiatry. 2018 Mar 5. doi: 10.1055/a-0573-9866.
    PubMed     Text format     Abstract available


    January 2018
  3. DEMBLER-STAMM T, Fiebig J, Heinz A, Gallinat J, et al
    Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls.
    Pharmacopsychiatry. 2018 Jan 29. doi: 10.1055/s-0044-100627.
    PubMed     Text format     Abstract available


    July 2017
  4. LI XB, Zheng W, Ning YP, Cai DB, et al
    Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review.
    Pharmacopsychiatry. 2017 Jul 17. doi: 10.1055/s-0043-114670.
    PubMed     Text format     Abstract available


  5. NAGAI N, Tani H, Suzuki T, Ikai S, et al
    Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey.
    Pharmacopsychiatry. 2017 Jul 4. doi: 10.1055/s-0043-113828.
    PubMed     Text format     Abstract available


  6. MAURI MC, Paletta S, Di Pace C, Reggiori A, et al
    Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability.
    Pharmacopsychiatry. 2017;50:145-151.
    PubMed     Text format     Abstract available


    May 2017
  7. SCHENNACH R, Obermeier M, Seemuller F, Jager M, et al
    Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?
    Pharmacopsychiatry. 2017 May 15. doi: 10.1055/s-0043-106436.
    PubMed     Text format     Abstract available


    February 2017
  8. NOVICK D, Montgomery W, Treuer T, Moneta MV, et al
    Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms.
    Pharmacopsychiatry. 2017 Feb 16. doi: 10.1055/s-0042-112818.
    PubMed     Text format     Abstract available


    October 2016
  9. LAMBERT M, Niehaus V, Correll C
    Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


  10. TRINCZEK E, Heinzel-Gutenbrunner M, Haberhausen M, Bachmann CJ, et al
    Time to Initiation of Clozapine Treatment in Children and Adolescents with Early-Onset Schizophrenia.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


    September 2016
  11. FUJIOI J, Iwamoto K, Banno M, Kikuchi T, et al
    Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


    July 2016
  12. LANGGARTNER S, Strube W, Oviedo T, Hansbauer M, et al
    Treatment-resistant Schizophrenia and Global Cortical Atrophy in a Patient with Turner Syndrome.
    Pharmacopsychiatry. 2016.
    PubMed     Text format    


  13. DARAY FM, Rodante D, Carosella LG, Silva ME, et al
    -759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


    February 2016
  14. AMIAZ R, Rubinstein K, Czerniak E, Karni Y, et al
    A Diet and Fitness Program Similarly Affects Weight Reduction in Schizophrenia Patients Treated with Typical or Atypical Medications.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


  15. NIKBAKHAT MR, Arabzadeh S, Zeinoddini A, Khalili Z, et al
    Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


  16. RYU S, Huh IS, Cho EY, Cho Y, et al
    Association Study of 60 Candidate Genes with Antipsychotic-induced Weight Gain in Schizophrenia Patients.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


    January 2016
  17. JI S, Li A, Wu K, Deng C, et al
    Brief Questionnaire Derived from PANSS Using a General Probability Model to Assess and Monitor the Clinical Features of Schizophrenia.
    Pharmacopsychiatry. 2016.
    PubMed     Text format     Abstract available


  18. SI T, Fan J, Wang X, Wang C, et al
    A Subgroup Analysis of Chinese Patients Switched to Paliperidone Palmitate One-Month Injectable by Prior Oral Antipsychotic Treatment.
    Pharmacopsychiatry. 2016;49:32-41.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: